Here’s the press launch…

Parallel, one of many largest privately held, vertically built-in, multi-state hashish firms on this planet, at present appointed Walgreen’s veteran Jeremy Kunicki as its Chief Financial Officer (CFO), efficient instantly. Parallel introduced final week that it intends to develop into a public firm via a definitive enterprise mixture settlement with Ceres Acquisition Corp., a particular objective acquisition company (SPAC). As CFO, Kunicki will lead Parallel’s finance and operations features, as effectively as oversee company finance, shared providers actions and operational administration of the group. James Whitcomb, who had served as Parallel’s Interim CFO, will proceed in his function as Chief Development Officer.

Kunicki joins Parallel from Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the place he most lately served as CFO for the Walgreens division, one of many largest retail pharmacy firms in the United States. In this place, Kunicki led Walgreens’ finance group for the U.S. enterprise and was accountable for monetary oversight of investments, monetary planning, efficiency administration and enterprise growth. Throughout his 20 years at Walgreens, he performed numerous finance management roles with a particular concentrate on operations, provide chain, actual property, digital and IT. Kunicki has additionally lead company-wide value transformation packages, and oversaw finance for M&A integrations. Kunicki holds a Master of Accountancy from the University of Wisconsin-Madison.

“We are thrilled to welcome Jeremy to Parallel’s executive leadership team, especially at this momentous time for our company. Jeremy’s expertise in translating strategy into tangible corporate initiatives that drive growth will be a vital asset as Parallel continues to scale as a national cannabis well-being company. Most importantly, his community-focused values, passion for prioritizing consumer health and track record of building high performance teams align perfectly with our culture,” mentioned William “Beau” Wrigley, Jr., Chief Executive Officer and Chairman of Parallel.

“I am excited to join Parallel as it prepares to become a publicly traded company. In a few short years, Parallel has differentiated itself as a leader in the cannabis industry, with strong revenue growth, an exceptional and seasoned leadership team, and a customer, community, and employee-centric vision,” mentioned Jeremy Kunicki, CFO of Parallel. “I look forward to working with the Parallel team to pioneer consumer and patient well-being through the benefits of cannabinoids.”

About Parallel

Parallel is without doubt one of the largest privately held, vertically built-in, multi-state hashish firms on this planet with a mission to pioneer well-being and enhance the standard of life via cannabinoids. Parallel owns and operates retail dispensaries in 4 medical and adult-use markets: Surterra Wellness in Florida and TexasNew England Treatment Access (NETA) in Massachusetts, and The Apothecary Shoppe in Nevada. Parallel additionally has a license beneath its Goodblend model in Pennsylvania for vertically built-in operations and as much as six retail areas, along with a medical hashish analysis partnership with the University of Pittsburgh School of Medicine. The Company has a various portfolio of top of the range, proprietary and licensed client manufacturers and merchandise together with Surterra WellnessCoral ReeferFloat and Heights. Parallel operates roughly 50 areas nationwide, together with 42 retail shops and cultivation and manufacturing websites. The Company, via its wholly-owned Parallel Biosciences subsidiary, conducts superior hashish science and R&D for brand new product growth in its amenities in TexasMassachusettsFlorida, and Budapest, Hungary. Parallel follows rigorous operations and enterprise practices to make sure the standard, security, consistency and efficacy of its merchandise and is constructing its enterprise by following sturdy values and placing the well-being of its clients and staff first. Find extra data at, or on Instagram and LinkedIn.

More at

Source link